Nabi says nicotine vaccine fails again

Nabi Biopharmaceuticals Inc. said Wednesday that its anti-smoking vaccine NicVAX failed in another clinical trial, as a combination of NicVAX and Pfizer’s smoking-cessation pill Chantix was no better than Chantix alone in helping patients quit. Patients in the trial took either Chantix or Chantix …